Bank Of New York Mellon Corp Lexicon Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $586,832 - $834,606	326,018 New	326,018 $622,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $67,054 - $118,554	34,564 Added 13.44%	291,660 $699,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $36,043 - $74,012	-27,514 Reduced 9.67%	257,096 $478,000
Q1 2022 May 11, 2022	BUY	$1.95 - $3.89 $705 - $1,408	362 Added 0.13%	284,610 $595,000
Q4 2021 Feb 11, 2022	BUY	$3.81 - $6.16 $88,612 - $143,269	23,258 Added 8.91%	284,248 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$3.38 - $5.35 $66,433 - $105,154	19,655 Added 8.14%	260,990 $1.26 Million
Q2 2021 Aug 11, 2021	BUY	$4.12 - $5.87 $164,466 - $234,324	39,919 Added 19.82%	241,335 $1.11 Million
Q1 2021 May 13, 2021	BUY	$3.45 - $9.09 $47,682 - $125,632	13,821 Added 7.37%	201,416 $1.18 Million
Q4 2020 Feb 09, 2021	SELL	$1.05 - $3.67 $337,754 - $1.18 Million	-321,671 Reduced 63.16%	187,595 $641,000
Q3 2020 Nov 12, 2020	SELL	$1.44 - $2.1 $89,402 - $130,378	-62,085 Reduced 10.87%	509,266 $733,000
Q2 2020 Aug 12, 2020	SELL	$1.75 - $2.3 $306,099 - $402,302	-174,914 Reduced 23.44%	571,351 $1.14 Million
Q1 2020 May 06, 2020	SELL	$1.8 - $4.28 $87,499 - $208,055	-48,611 Reduced 6.12%	746,265 $1.46 Million
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $1.93 Million - $3.14 Million	609,611 Added 329.05%	794,876 $3.3 Million
Q3 2019 Nov 07, 2019	SELL	$1.2 - $6.66 $6,748 - $37,455	-5,624 Reduced 2.95%	185,265 $557,000
Q2 2019 Aug 12, 2019	SELL	$5.35 - $7.11 $28,419 - $37,768	-5,312 Reduced 2.71%	190,889 $1.2 Million
Q1 2019 May 14, 2019	BUY	$4.36 - $7.94 $38,359 - $69,856	8,798 Added 4.69%	196,201 $1.09 Million
Q4 2018 Feb 11, 2019	SELL	$6.15 - $10.51 $8,216 - $14,041	-1,336 Reduced 0.71%	187,403 $1.24 Million
Q3 2018 Nov 09, 2018	SELL	$10.32 - $13.06 $77,100 - $97,571	-7,471 Reduced 3.81%	188,739 $0
Q2 2018 Aug 06, 2018	SELL	$7.8 - $13.69 $59,412 - $104,276	-7,617 Reduced 3.74%	196,210 $2.35 Million
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $28,130 - $40,764	3,579 Added 1.79%	203,827 $1.75 Million
Q4 2017 Feb 09, 2018	BUY	$8.77 - $12.28 $1.76 Million - $2.46 Million	200,248	200,248 $1.98 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account